A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS | MicrobiomeTrials← Back to trialsNCT07084012
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-08-27Est. Completion: 2027-05-31
Enrollment target: 60 participants Locations- Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Acute Ischemic Stroke (AIS)
Acute ischemic stroke caused by blockage of a large artery in the brain is one of the leading causes of death and long-t…
Suzhou, ChinaEst. completion May 31, 2028
Acute Ischemic Stroke (AIS)
The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a pat…
Nedlands, AustraliaEst. completion Jan 2028